A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity

Part of paid clinical trials in Cypress, California.

Sponsor
Novo Nordisk A/S
Study ID
NCT07101783
Phase
PHASE1
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 55 Years
Healthy Volunteers
Not accepted

Interventions

  • NNC0662-0419 — DRUG
    Participants will receive NNC0662-0419 subcutaneously.

Study Details

The study is testing the new medicine NNC0662-0419 in people living with overweight or obesity. The purpose of the study is to look into the amount of the new medicine NNC0662-0419 in participants blood after one dose. And also look into how safe and how well the study medicine is tolerated in people living with overweight or obesity. NNC0662-0419 is a new medicine which cannot be prescribed by doctors. NNC0662-0419 is currently being tested in humans and the dose participants will receive has been found safe and tolerable. Participants will get a single dose of NNC0662-0419 given by study staff as a single injection under participants skin. Like all medicines, the study medicine may have side effects. The study will last up to 2 months.

Key Dates

Start date
Aug 1, 2025
Status verified
Dec 2025
Primary completion
Oct 31, 2025
Completion
Oct 31, 2025

Study Design

Enrollment
100 participants (actual)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: NNC0662-0419 (Dose 1)
    Participants will receive a single dose (SD) of NNC0662-0419 subcutaneously.
  • Experimental: NNC0662-0419 (Dose 2)
    Participants will receive a SD of NNC0662-0419 subcutaneously.
  • Experimental: NNC0662-0419 (Dose 3)
    Participants will receive a SD of NNC0662-0419 subcutaneously.

Primary Outcome Measure

AUC; The area under the NNC0662-0419 plasma concentration-time curve [ Time Frame: From pre-dose on Day 1 until completion of the end of study visit (Day 29) ]

Locations (1)

FacilityCityStateZIPSite coordinators
Altasciences Clinical LA, Inc.CypressCalifornia90630-

Find similar trials in Cypress, CA

By condition
Obesity / overweight
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Altasciences Clinical LA, Inc.· Cypress, CA

Related Studies